Page last updated: 2024-10-26

donepezil and Acquired Communication Disorders

donepezil has been researched along with Acquired Communication Disorders in 1 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Research Excerpts

ExcerptRelevanceReference
"Language impairment in Alzheimer's disease primarily occurs because of decline in semantic and pragmatic levels of language processing."2.49Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors. ( Farlow, M; Ferris, SH, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferris, SH1
Farlow, M1

Reviews

1 review available for donepezil and Acquired Communication Disorders

ArticleYear
Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors.
    Clinical interventions in aging, 2013, Volume: 8

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Communication Disorders; Donepezil; Galantamine; Human

2013